Br J Cancer 2006, 95: 1265–8.CrossRefPubMed
23. Giordano L, Giorgi D, Piccini P, Ventura L, Stefanini V, Senore C, Paci E, Segnan N: Time trends of process and impact indicators in Italian mammography screening programs 1994–2004. Epidemiol Prev 2007, 31 (2–3 Suppl 2) : 21–32.PubMed 24. Grazzini G, Zappa M: Attendance in cancer screening programmes in Italy. Italian J Public Health Year 6 2008, 5 (2) : 117–124. Competing interests The authors declare that they have no competing interests. Authors’ contributions PP, AS, FMB, MDM, AG conceived of the study, and participated in its design and coordination; GI, FG, AM, AD, MLB, MC, AG participated in the design of the study; GS, ES, FA, MS, AF carried out the clinical AMN-107 re-evaluation of the
study results. All authors have read and approved the final manuscript.”
“Background In the United States alone, 200,000 selleck chemicals llc men are diagnosed with prostate cancer each year and one out of six men will be diagnosed in their lifetime. As many as 30,000 men die from this disease each year in the US, making prostate cancer the second P505-15 price biggest cancer killer of men, behind lung cancer[1]. However, several distinct features of the prostate gland open up unique opportunities for treatment of this cancer. First, the prostate is a nonessential organ, often making complete surgical resection a viable option, albeit one with permanent unpleasant side effects for the patient. Secondly, during early phases of the disease, the malignant prostatic lesions tend to remain focal and restrictively localized to the prostate gland itself. This, combined with the anatomic accessibility of the prostate gland, makes direct intra-tumoral injection of carcinotoxic and carcinostatic agents a real possibility for effective and relatively noninvasive treatment[2]. In this study, Methane monooxygenase based in part on promising
in vitro results from our laboratory, we explore the effectiveness of direct intra-tumoral injection of zinc acetate into malignant prostatic tumors. Zinc is the most abundant trace element in the human body and is vital for the function of many enzymes and proteins in all cells and tissues of the body. There are over 300 zinc-dependent enzymes and zinc is required for the formation of the zinc-finger motif that is an essential component for nearly all transcription factors and many other proteins that bind nucleic acids[3]. It has long been known that chronic insufficient dietary zinc leads to many debilitating developmental defects, but emerging evidence now links marginally deficient zinc consumption, such as that which affects more than 10% of the US population, to such diseases as anorexia nervosa, Ahlzeimer’s Disease, and cancer.
Related posts:
- Cancer Genet Cytogenet 2003, 140: 145–152 CrossRefPubMed 10 Cher
- Mol Cell Biochem 2006, 286: 67–76 PubMedCrossRef 13 Fong WG, Lis
- Vincristine leurocristine authors meet the criteria for authorship as recommended
- XL880 approved and emotion Promoted by the Cancer Therapy Evaluation Program at the National Cancer Institute
- Br J Cance 1998, 77:1799–1805 CrossRef 30 Westermarck J, Kähäri